Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

DiaSorin S.p.A.

DSRLF
Current price
99.86 USD 0 USD (0.00%)
Last closed 102.05 EUR
ISIN IT0003492391
Sector Healthcare
Industry Diagnostics & Research
Exchange MI
Capitalization 5 572 360 902 EUR
Yield for 12 month +14.34 %
1Y
3Y
5Y
10Y
15Y
DSRLF
21.11.2021 - 28.11.2021

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy. Address: Via Crescentino, Saluggia, VC, Italy, 13040

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

90.25 EUR

P/E ratio

34.3234

Dividend Yield

1.13 %

Current Year

+1 143 818 588 EUR

Last Year

+1 355 932 229 EUR

Current Quarter

+299 057 841 EUR

Last Quarter

+287 894 698 EUR

Current Year

+666 524 044 EUR

Last Year

+897 168 540 EUR

Current Quarter

+197 175 991 EUR

Last Quarter

+191 265 682 EUR

Key Figures DSRLF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 324 827 847 EUR
Operating Margin TTM 23.09 %
PE Ratio 34.3234
Return On Assets TTM 4.69 %
PEG Ratio 1.4468
Return On Equity TTM 10.75 %
Wall Street Target Price 90.25 EUR
Revenue TTM 1 156 585 619 EUR
Book Value 30.19 EUR
Revenue Per Share TTM
Dividend Share 1.15 EUR
Quarterly Revenue Growth YOY 4.7 %
Dividend Yield 1.13 %
Gross Profit TTM 897 168 540 EUR
Earnings per share 3.02 EUR
Diluted Eps TTM 3.02 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 7.7 %
Profit Margin 14.45 %

Dividend Analytics DSRLF

Dividend growth over 5 years

29 %

Continuous growth

3 years

Payout Ratio 5 years average

31 %

Dividend History DSRLF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.15
Ex Dividend Date 20.05.2024
Forward Annual Dividend Yield 1.13 %
Last Split Factor
Payout Ratio 36.86 %
Last Split Date
Dividend Date

Stock Valuation DSRLF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 34.3234
Forward PE 22.1239
Enterprise Value Revenue 5.3859
Price Sales TTM 4.8179
Enterprise Value EBITDA 16.5909
Price Book MRQ 3.3669

Financials DSRLF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DSRLF

For 52 weeks

80.02 EUR 105.64 EUR
50 Day MA 101.14 EUR
Shares Short Prior Month
200 Day MA 94.37 EUR
Short Ratio
Shares Short
Short Percent